Biofrontera
BFRI · NASDAQ
$0.804−$0.0017 (−0.21%)TodayMarket closed ·
Prev close $0.8057
About BFRI
- Employees
- 84
- Headquarters
- Woburn, Massachusetts
- Listed
- Oct 14, 2021
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- biofrontera-us.com
BFRI key statistics
- Market cap
- 11.94M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 337.79K
- Volume
- 72.75K
- Open price
- $0.8227
- High today
- $0.8299
- Low today
- $0.80
- 52 Week high
- $1.66
- 52 Week low
- $0.5547
Biofrontera (BFRI) at a glance
Biofrontera (BFRI) last traded at $0.804, with a market cap of 11.94M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.80 and $0.8299. The current price is 0.5% above the day's low and 3.1% below its high.
Volume so far is 72.75K shares, below the average of 337.79K shares a day.
Over the past year Biofrontera has ranged from $0.5547 to $1.66, and now sits 23% of the way up that range.
Biofrontera met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.05 per share against an estimate of -$0.1071.
The average analyst price target is $6.12, 661.2% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 1 analyst rating say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 4 analystsAvg $6.12
- Low
- $3.03
- Now
- $0.804
- High
- $9.45
BFRI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 98.1% on average.
- Q3 FY24: reported -$0.98 per share against an estimate of -$0.8517
- Q4 FY24: reported -$0.25 per share against an estimate of -$0.0255
- Q1 FY25: reported -$0.47 per share against an estimate of -$0.2193
- Q2 FY25: reported -$0.57 per share against an estimate of -$0.4284
- Q3 FY25: reported -$0.62 per share against an estimate of -$0.5916
- Q4 FY25: reported $0.483 per share against an estimate of $0.1989
- Q1 FY26: reported -$0.37 per share against an estimate of -$0.1173
- Q2 FY26: reported -$0.05 per share against an estimate of -$0.1071
BFRI news
- Press releaseGlobe Newswire
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones
Biofrontera Earnings Preview
- Vandana Singh
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch
A Look at Biofrontera's Upcoming Earnings Report
Earnings Outlook For Biofrontera
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Similar companies
Companies in the same industry as Biofrontera
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.